Infectious complications among CD19 CAR‐T cell therapy recipients: A single‐center experience

Background CD19 chimeric antigen receptor (CAR)‐T cell therapy has emerged as an effective treatment in those with refractory or relapsed lymphoma. CD19 CAR‐T cell therapy can cause direct and indirect toxic adverse effects and increased risk for infection. Infectious complications and optimal antim...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Transplant infectious disease 2023-11, Vol.25 (S1), p.e14191-n/a
Hauptverfasser:	Walker, Bryan, Zimmer, Andrea J., Stohs, Erica J., Lunning, Matthew, Lyden, Elizabeth, Abbas, Anum
Format:	Artikel
Sprache:	eng
Schlagworte:	Anti-Infective Agents Antibiotics Antigens, CD19 Bacterial diseases Bacterial infections CD19 antigen CD19 CAR‐T cell therapy Cell therapy Cell- and Tissue-Based Therapy chimeric antigen receptor Chimeric antigen receptors Disease prevention Electronic health records Electronic medical records Fusariosis Humans Immunotherapy, Adoptive - adverse effects Infections infectious complications Lymphocytes Lymphocytes T Lymphoma Neutropenia Optimization Patients Prophylaxis Receptors, Chimeric Antigen - therapeutic use Recurrent infection Retrospective Studies Sinusitis Soft tissues Statistical analysis Stem cell transplantation Stem cells Therapy Viral infections
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!